意外儿科死亡:一个十年的回顾性队列
Emily Jane Devereaux1, Robert Porter2, Nash Denic2
1Dalhousie University Faculty of Health, 5968 College Street, PO BOX 15000, Halifax, NS, B3H 4R2, Canada. emily.devereaux@dal.ca.
BMC pediatrics
|November 12, 2025
概括
分析了纽芬兰和拉布拉多 (NL) 的儿童意外死亡. 农村地区的发病率较高,主要原因是机动车辆碰撞,与其他加拿大省份不同.
科学领域:
- 儿科公共卫生 儿科公共卫生
- 伤害预防 预防伤害
- 流行病学 流行病学
背景情况:
- 意外死亡是全球儿童死亡的主要原因.
- 有限的数据存在于纽芬兰和拉布拉多 (NL) 的儿科意外死亡.
研究的目的:
- 评估荷兰的儿童和青少年 (0-21岁) 意外死亡的发生率和模式.
- 将这些模式与加拿大其他省份进行比较,特别是新不伦瑞克 (NB) 和曼尼托巴 (MB).
主要方法:
- 一项回顾性队列研究分析了从2004年到2013年向荷兰首席法医办公室 (OCME) 提交的案件.
- 对NL,NB和MB的数据进行了比较,根据年龄和发生年份进行了匹配.
主要成果:
- 确定了139例意外死亡病例,男性不成比例地受到影响.
- 机动车碰撞 (MVC) 是主要原因 (52%).
- 在NL内观察到显著的区域差异,农村地区和拉布拉多格林菲尔健康地区的发病率更高.
结论:
- 在NL地区,意外死亡的发生率差异很大,农村地区的人均死亡率更高.
- 总体而言,NL的意外死亡率,原因和性别分布与MB相似,但低于NB.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Drug Dosing: Infants and Children
237
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
237
Actuarial Approach
281
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
281


